CD93 and acute myeloid leukemia: developed a new humanized CD93‐specific binding protein and evaluated the role of CD93 CAR‐T cells in leukaemia, and in vivo experiments showed that CD93 CAR‐T cells specifically cleared AML but not HSPC.92